MED1 and breast carcinoma: Our study supports that miR-205 plays an important role in mediating tamoxifen resistance through regulating both MED1 expression and activation, and, thus, miR-205 re-expression could represent a more efficient and advantageous approach to overcome tamoxifen resistance in breast cancer.